Uploaded July 2025 | Updated September 2026, 1 week ago

---

Scientists are using supercomputers, machine learning, and automation to discover antibodies that protect against emerging pathogens. The Generative Unconstrained Intelligent Drug Engineering (GUIDE) program accelerates development of medical countermeasure candidates to redefine biological defense. Read more about it in Science & Technology Review.

str.llnl.gov/str-september-2024

LLNL-VIDEO-2001687